tetano
Editor, Senior Moderator
Cureus
. 2020 May 8;12(5):e8034.
doi: 10.7759/cureus.8034.
A Review of Cardiac Complications in Coronavirus Disease 2019
Romil Singh[SUP] 1 [/SUP], Rahul Kashyap[SUP] 2 [/SUP], Anneka Hutton[SUP] 3 [/SUP], Munish Sharma[SUP] 4 [/SUP], Salim Surani[SUP] 4 5 [/SUP]
Affiliations
Abstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has shown an association with acute myocardial injury, cardiomyopathy, and myocarditis. Individuals with myocardial involvement in association with the coronavirus disease 2019 (COVID-19) may be at increased risk of developing severe illness. Cardiomyopathies are a heterogeneous group of diseases of the myocardium associated with mechanical and/or electrical dysfunction that usually exhibit inappropriate ventricular hypertrophy or dilation and are due to a variety of causes that frequently are genetic. It has been primarily divided into three subsets: genetic, mixed, and acquired cardiomyopathy. We anticipate that, because of the high inflammatory response, other cardiovascular complications may also occur in COVID-19 patients with severe symptoms. This review explores new information as it pertains to COVID-19 and cardiac complications.
Keywords: cardiomyopathy; covid 19; heart failure; novel coronavirus; sars-cov-2.
. 2020 May 8;12(5):e8034.
doi: 10.7759/cureus.8034.
A Review of Cardiac Complications in Coronavirus Disease 2019
Romil Singh[SUP] 1 [/SUP], Rahul Kashyap[SUP] 2 [/SUP], Anneka Hutton[SUP] 3 [/SUP], Munish Sharma[SUP] 4 [/SUP], Salim Surani[SUP] 4 5 [/SUP]
Affiliations
- PMID: 32528770
- PMCID: PMC7282366
- DOI: 10.7759/cureus.8034
Abstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has shown an association with acute myocardial injury, cardiomyopathy, and myocarditis. Individuals with myocardial involvement in association with the coronavirus disease 2019 (COVID-19) may be at increased risk of developing severe illness. Cardiomyopathies are a heterogeneous group of diseases of the myocardium associated with mechanical and/or electrical dysfunction that usually exhibit inappropriate ventricular hypertrophy or dilation and are due to a variety of causes that frequently are genetic. It has been primarily divided into three subsets: genetic, mixed, and acquired cardiomyopathy. We anticipate that, because of the high inflammatory response, other cardiovascular complications may also occur in COVID-19 patients with severe symptoms. This review explores new information as it pertains to COVID-19 and cardiac complications.
Keywords: cardiomyopathy; covid 19; heart failure; novel coronavirus; sars-cov-2.